Related Experiment Video
Updated: Jul 9, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
[The influence of the pharmaceutical industry in patient organisations]
1Academisch Medisch Centrum/Universiteit van Amsterdam, Afd. Neurologie, H2-227, Postbus 22.700, 1100 DE Amsterdam. m.vermeulen@amc.uva.nl
Abstract:
Most patient organisations have no objection to sponsoring by the pharmaceutical industry. Only 5% of all organisations are against sponsoring. When patient organisations were asked whether or not their activities could continue without sponsoring, 42% answered no, 6% yes, and 52% felt that they might continue, but restricted. In a report of the public health inspector on the subject, transparency is considered to be a remedy for the entanglement between patient organisations and the pharmaceutical industry. However, the authors doubt that this is effective. The government should provide sufficient support for patient organisations so that they can become independent from the industry.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Regulation
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmaceutical Poisoning: Potential Scenarios

